BCL46 and other genomic alterations in nonmHodgkin's lymphoma (NHL)
1997

Genomic Alterations in Non-Hodgkin's Lymphoma

Sample size: 94 publication Evidence: moderate

Author Information

Author(s): M Butler, N Corbally, PA Dervan, DN Carney

Primary Institution: Mater Misericordiae Hospital, University College Dublin

Hypothesis

What is the frequency and disease specificity of BCL-1, BCL-2, c-MYC, and BCL-6 gene rearrangements in non-Hodgkin's lymphoma?

Conclusion

The study found significant associations between specific genomic alterations and defined subtypes of non-Hodgkin's lymphoma.

Supporting Evidence

  • 60% of mantle cell lymphomas had BCL-1 rearrangements.
  • BCL-2 was rearranged in 42% of follicle centre lymphomas.
  • 31% of diffuse large B-cell lymphomas showed BCL-6 rearrangements.
  • 50% of BCL-6 rearrangement positive cases had coexisting gene rearrangements.

Takeaway

This study looked at how often certain genes are changed in lymphoma, which helps us understand different types of this cancer better.

Methodology

Fresh-frozen lymph node biopsy specimens were obtained and analyzed for gene rearrangements using Southern blot analysis.

Limitations

The study may not capture all genetic alterations due to the focus on specific genes and the use of a single probe for BCL-2.

Participant Demographics

Patients were from the Irish population attending the Mater Misericordiae Hospital.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication